IP Library Granted Patent US 10,000,802
Granted Patent B2
US 10,000,802 · App. 14/682,401 · Granted Jun 19, 2018

Sequencing method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,000,802
App. No.
14/682,401
Granted
Jun 19, 2018
Kind
B2
Abstract

Disclosed is a method for determining the sequence of nucleotide bases in a polynucleotide analyte characterised by the steps of: a. generating a stream of droplets at least some of which contain a single nucleotide and wherein the order of single nucleotides in the droplet stream corresponds to the sequence of nucleotides in the analyte; b. introducing into each droplet a plurality of biological probe types each type (i) comprising a different detectable element in an undetectable state and (ii) being adapted to capture a different complimentary single nucleotide from which the analyte is constituted; c. causing the single nucleotide contained in the droplet to bind to its complimentary probe to create a used probe; and d. causing the detectable element to be released from the used probe in a detectable state. Typically the biological probe employed comprises a single-stranded nucleotide region the ends of which are attached to two different oligonucleotide regions wherein at least one of the oligonucleotide regions comprises detectable elements having a characteristic detection property and wherein the detectable elements are so arranged on the oligonucleotide region that the detectable property is essentially undetectable in the probe's unused state. In a most preferred embodiment the probe is labelled with multiple fluorophores and further comprises a restriction enzyme recognition site generated by the binding of the target single nucleotide to the single-stranded nucleotide region. Suitably, step c is carried out in the presence of a polymerase and ligase and step d in the presence of a restriction enzyme and an exonuclease. Typically the flow rate of the droplets is 100 to 2000 droplets per second.

Claims (17)

1. A microfluidic device for sequencing a nucleic acid analyte comprising:

a first microfluidic pathway for providing an aqueous stream of single nucleotides whose ordering corresponds to the sequence of the analyte comprising a flowing aqueous medium pathway and an analyte located on an internal surface thereof, wherein the first microfluidic pathway is connected to a first microdroplet-generating head;

a first chamber attached to the first microdroplet-generating head and comprising a carrier solvent inlet and an outlet for removing a stream of first microdroplets in the carrier solvent therefrom, wherein the first microdroplet-generating head introduces an aqueous medium associated with the aqueous medium pathway into the first chamber;

a second microfluidic pathway attached to the outlet of the first chamber,

a second chamber within the second microfluidic pathway and comprising a second microdroplet-generating head for introducing enzymes and biological probes into the first microdroplets in the second chamber;

a storage zone downstream of the second chamber comprising locations at which the microdroplets issuing from the second microdroplet pathway are stored;

a light source for interrogating the microdroplet locations; and

a photodetector for detecting fluorescence at the microdroplet locations.

2. The microfluidic device of claim 1 , wherein the storage zone is a cartridge or channel.

3. The microfluidic device of claim 2 , wherein at least one face of the cartridge or channel is transparent.

4. The microfluidic device of claim 1 , wherein the first microdroplet-generating head is adapted to produce microdroplets of less than 50 microns in diameter.

5. The microfluidic device of claim 1 , wherein a third microfluidic pathway is connected to the second chamber, and the third microfluidic pathway is also connected to a third chamber comprising an inlet comprising a third microdroplet-generating head for introducing a catalyst into the third chamber.

6. The microfluidic device of claim 1 , wherein an internal surface of the second microfluidic pathway includes a hydrophobic coating or a hydrophobic surface modification.

7. The microfluidic device as claimed in claim 1 , further comprising an external scanner to deflect the light source across the microdroplets.

8. The microfluidic device as claimed in claim 1 , wherein the light source is a laser.

9. The microfluidic device as claimed in claim 1 , wherein the photodetector is an sCMOS camera and the microdroplet locations are interrogated using a light source comprising a plurality of lasers and a dichroic mirror.

10. A method of sequencing a single-stranded polynucleotide comprising the step of determining a sequence of nucleotide bases in a single-stranded polynucleotide with the microfluidic device of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2022
From: BASE4 INNOVATION LTD
To: LIGHTCAST DISCOVERY LTD
Reel/Frame 061559/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2015
From: FRAYLING, CAMERON ALEXANDER; BALMFORTH, BARNABY; SOARES, BRUNO FLAVIO NOGUEIRA DE SOUSA; ISSAC, THOMAS HENRY; BREINER, BORIS; NATALE, ALESSANDRA; AMASIO, MICHELE
To: BASE4 INNOVATION LTD
Reel/Frame 036557/0320 →
Cited By (1)
US 12,391,987